Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01023711 · ClinicalTrials.gov registry record · NA
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
A NA study of Influenza, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 107
- Enrollment target
- 1
- Study location
NCT01023711: Completed NA study of Influenza, sponsored by University of Rochester.
NCT01023711 is a NA study of Influenza that has completed, run by University of Rochester. The registered enrollment target is 107 participants, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01023711, a NA study of Influenza, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 107 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to describe the immune response to a novel H1N1 influenza vaccination in healthy adults, and to understand the factors that allow healthy adults to respond to a single dose of vaccine even if they have never previously experience novel H1N1 disease or vaccination.
Primary Outcome
Number of participants with a 4-fold or greater increase in serum HAI antibody from pre- to 28 day post-vaccination
Conditions Studied
Interventions
- BIOLOGICAL Inactivated H1N1 vaccine
Study Locations (1)
New York
- Vaccine Research Unit Room 3-5000 - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 107 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01023711 record still lists
NCT01023711 is an interventional study that assigns participants to a tested intervention. The registered 107 participants enrollment target is mid-sized for trials with a published cap, below the 36,803-participant average among 156 other Influenza trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Influenza appearing as the primary indexed condition, and to 1 intervention - of which Inactivated H1N1 vaccine is the first listed.
NCT01023711 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT01023711 about?
NCT01023711 is a clinical study titled "Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus". The purpose of this study is to describe the immune response to a novel H1N1 influenza vaccination in healthy adults, and to understand the factors that allow healthy adults to respond to a single dose of vaccine even if they have never previously experience novel H1N1 disease or vaccination.
What is the current status of trial NCT01023711?
This trial is currently completed. It is a NA study. The enrollment target is 107 participants. The study started on 2009-11. Estimated completion is 2011-07.
What conditions does trial NCT01023711 study?
This clinical trial studies the following conditions: Influenza.
What interventions are being tested in trial NCT01023711?
The interventions under investigation include: Inactivated H1N1 vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT01023711?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01023711 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Influenza
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01023711's enrollment target sits among peer trials
107 100th of 156 higher than 57 of 156 other Influenza trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Influenza trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Influenza Immunization in Adults Over Age 75
RECRUITING · NA
-
H5N1 Milk Detection Study
RECRUITING · NA
-
Immune Defense Protein Impact On Respiratory Immune Outcomes
RECRUITING · NA
-
Dime La VerDAD: Verify, Debunk, and Disseminate
RECRUITING · NA
-
The INFLUENTIAL Trial- Evaluation of National Inpatient Influenza Vaccination Program
RECRUITING · NA
-
Impact of High Dietary Fiber on Microbiome and Vaccine Responses
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491668 · 107 participants
Physiological Assessment of Severe Coronary Stenosis for Informing Planned PCI
- NCT06041594 · 107 participants · NA
Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)
- NCT06081426 · 107 participants · NA
Examining Neurobiological Mechanisms Underlying the Therapeutic Effect of the Ketogenic Diet in Bipolar Disorder (BD)
- NCT06527599 · 107 participants · NA
Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia